BR, W., CJ, P., WJ, R., SM, H., WD, F., & RM, S. (2022). Pharmacokinetics and tolerability of the dual TORC1/2 inhibitor sapanisertib in combination with the MEK inhibitor trametinib in dogs. Frontiers in veterinary science, 9, 1056408. https://doi.org/10.3389/fvets.2022.1056408
Chicago Style (17th ed.) CitationBR, Wei, Peer CJ, Richardson WJ, Hewitt SM, Figg WD, and Simpson RM. "Pharmacokinetics and Tolerability of the Dual TORC1/2 Inhibitor Sapanisertib in Combination with the MEK Inhibitor Trametinib in Dogs." Frontiers in Veterinary Science 9 (2022): 1056408. https://doi.org/10.3389/fvets.2022.1056408.
MLA (9th ed.) CitationBR, Wei, et al. "Pharmacokinetics and Tolerability of the Dual TORC1/2 Inhibitor Sapanisertib in Combination with the MEK Inhibitor Trametinib in Dogs." Frontiers in Veterinary Science, vol. 9, 2022, p. 1056408, https://doi.org/10.3389/fvets.2022.1056408.